Article information
Abstract
18F-FDG PET/CT has been positioned over time as a useful tool in the evaluation of osteoarticular infections, overcoming conventional explorations like MRI or bone scintigraphy in some indications. Its ability to provide functional and anatomical images simultaneously and its excellent resolution contributes to a more precise and personalised approach in the treatment of osteoarticular diseases such as spondylodiscitis. In addition, it has proven valuable in patients with suspected infection that is complex to diagnose or treat, improving detection in subclinical stages. However, some limitations have been identified, such as difficulty in the differential diagnosis of infection vs. inflammation (as in diabetic foot) or in the interpretation of patients with osteosynthesis materials. In this manuscript, we present a brief review providing general and practical information about the role of 18F-FDG PET/CT in infectious osteoarticular pathology, while part 2 discusses the role of 18F-FDG PET/CT in osteoarticular inflammation.
Keywords:
18F-FDG PET/CT
Osteoarticular infection
Spondylodiscitis
Osteomyelitis
Diabetic foot
Periprosthetic infection
Resumen
La 18F-FDG PET/TC se ha ido posicionando en el tiempo como una herramienta útil en la evaluación de infecciones osteoarticulares, superando en algunas indicaciones, a técnicas convencionales como la resonancia magnética o la gammagrafía ósea. Su capacidad para proporcionar imágenes funcionales y anatómicas simultáneamente y su excelente resolución, contribuye a un abordaje más preciso y personalizado en el tratamiento de las enfermedades osteoarticulares como la espondilodiscitis. Además, ha demostrado ser valioso en pacientes con sospecha de infección compleja, mejorando su detección en fases subclínicas. No obstante, existen algunas limitaciones, como la dificultad en el diagnóstico diferencial infección vs inflamación (como en pie diabético) o en la interpretación de pacientes con materiales de osteosíntesis. En este manuscrito, presentamos una breve revisión proporcionando información general y práctica acerca del papel de la 18F-FDG PET/TC en la patología osteoarticular infecciosa, mientras que en la parte 2 se aborda dicho papel en la inflamación osteoarticular.
Palabras clave:
18F-FDG PET/TC
Infección osteoarticular
Espondilodiscitis
Osteomielitis
Pie diabético
Infección periprotésica
Article
These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
S. Hess, S.H. Hansson, K.T. Pedersen, S. Basu, P.F. Høilund-Carlsen.
FDG-PET/CT in infectious and inflammatory diseases.
PET Clinics, 9 (2014), pp. 497-519
[2]
S. Vaidyanathan, C.N. Patel, A.F. Scarsbrook, F.U. Chowdhury.
FDG PET/CT in infection and inflammation—current and emerging clinical applications.
Clin Radiol, 70 (2015), pp. 787-800
[3]
R. Boellaard, R. Delgado-Bolton, W.J.G. Oyen, F. Giammarile, K. Tatsch, W. Eschner, et al.
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Eur J Nucl Med Mol Imaging, 42 (2015), pp. 328-354
[4]
C.J. Palestro.
Molecular imaging of infection: the first 50 years.
Semin Nucl Med, 50 (2020), pp. 23-34
[5]
E. Noriega-Álvarez, L. Domínguez Gadea, S. Sanz Viedma, M. del Prado Orduña Diez, M. Minoves Font, V. Peiró Valgañón, et al.
Medicina nuclear en el diagnóstico de las afecciones de la columna vertebral: papel de la imagen híbrida.
Rev Esp Med Nucl, 40 (2020), pp. 37-49
[6]
M. Raghavan, E. Lazzeri, C.J. Palestro.
Imaging of spondylodiscitis.
Semin Nucl Med, 48 (2018), pp. 131-147
[7]
E. Noriega-Álvarez, L. Domínguez Gadea, M.P. Orduña Diez, V. Peiró Valgañón, S. Sanz Viedma, R. García Jiménez.
Role of Nuclear Medicine in the diagnosis of musculoskeletal infection: a review.
Rev Esp Med Nucl Imagen Mol, 38 (2019), pp. 397-407
[8]
E. Lazzeri, A. Bozzao, M.A. Cataldo, N. Petrosillo, L. Manfrè, A. Trampuz, et al.
Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults.
Eur J Nucl Med Mol Imaging, 46 (2019), pp. 2464-2487
[9]
C. Smids, I.J.E. Kouijzer, F.J. Vos, T. Sprong, A.J.F. Hosman, J.W.J. de Rooy, et al.
A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis.
Infection, 45 (2017), pp. 41-49
[10]
G. Treglia, M. Pascale, E. Lazzeri, W. van der Bruggen, R.C. Delgado Bolton, A.W.J.M. Glaudemans.
Diagnostic performance of 18F-FDG PET/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis.
Eur J Nucl Med Mol Imaging, 47 (2020), pp. 1287-1301
[11]
K. Ito, K. Kubota, M. Morooka, K. Hasuo, H. Kuroki, A. Mimori.
Clinical impact of (18)F-FDG PET/CT on the management and diagnosis of infectious spondylitis.
Nucl Med Commun, 31 (2010), pp. 691-698
[12]
S. Hungenbach, K.S. Delank, M. Dietlein, P. Eysel, A. Drzezga, M.C. Schmidt.
18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis.
Nucl Med Commun, 34 (2013), pp. 1068-1074
[13]
S.J. Kim, K. Pak, K. Kim, J.S. Lee.
Comparing the diagnostic accuracies of F-18 fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spondylodiscitis: a meta-analysis.
Spine, 44 (2019), pp. E414-22
[14]
Y. Yin, X. Liu, X. Yang, J. Guo, Q. Wang, L. Chen.
Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
Spine J, 18 (2018), pp. 2323-2332
[15]
C. Lauri, E. Noriega-Álvarez, R.M. Chakravartty, O. Gheysens, A.W.J.M. Glaudemans, R.H.J.A. Slart, et al.
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance.
Eur J Nucl Med Mol Imaging, 51 (2024), pp. 2229-2246
[16]
C. Palestro, A. Clark, E. Grady, S. Heiba, O. Israel, A. Klitzke, et al.
Appropriate use criteria for the use of nuclear medicine in musculoskeletal infection imaging.
J Nucl Med, 62 (2021), pp. 1815-1831
[17]
C. Lauri, A.W.J.M. Glaudemans, G. Campagna, Z. Keidar, M. Muchnik Kurash, S. Georga, et al.
Comparison of white blood cell scintigraphy, FDG PET/CT and MRI in suspected diabetic foot infection: results of a large retrospective multicenter study.
JCM, 9 (2020), pp. 1645
[18]
E.J. Sella, D.M. Grosser.
Imaging modalities of the diabetic foot.
Clin Podiatr Med Surg, 20 (2003), pp. 729-740
[19]
C.J. Palestro, C. Love.
Nuclear medicine and diabetic foot infections.
Semin Nucl Med, 39 (2009), pp. 52-65
[20]
A. Llewellyn, J. Kraft, C. Holton, M. Harden, M. Simmonds.
Imaging for detection of osteomyelitis in people with diabetic foot ulcers: a systematic review and meta-analysis.
Eu J Radiol, 131 (2020),
[21]
G. Treglia, N. Quartuccio, R. Sadeghi, A. Farchione, C. Caldarella, F. Bertagna, et al.
Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.
J Crohns Colitis, 7 (2013), pp. 345-354
[22]
C. Lauri, M. Tamminga, A.W.J.M. Glaudemans, L.E. Juárez Orozco, P.A. Erba, P.C. Jutte, et al.
Detection of osteomyelitis in the diabetic foot by imaging techniques: a systematic review and meta-analysis comparing MRI, white blood cell scintigraphy, and FDG-PET.
Diabetes Care, 40 (2017), pp. 1111-1120
[23]
A. Signore, F. Jamar, O. Israel, J. Buscombe, J. Martin-Comin, E. Lazzeri.
Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.
Eur J Nucl Med Mol Imaging, 45 (2018), pp. 1816-1831
[24]
Z. Keidar, D. Militianu, E. Melamed, R. Bar-Shalom, O. Israel.
The diabetic foot: initial experience with 18F-FDG PET/CT.
J Nucl Med, 46 (2005), pp. 444-449
[25]
D. Familiari, A.W.J.M. Glaudemans, V. Vitale, D. Prosperi, O. Bagni, A. Lenza, et al.
Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?.
J Nucl Med, 52 (2011), pp. 1012-1019
[26]
A.W.J.M. Glaudemans, P.C. Jutte, M.A. Cataldo, V. Cassar-Pullicino, O. Gheysens, O. Borens, et al.
Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).
Eur J Nucl Med Mol Imaging, 46 (2019), pp. 957-970
[27]
V. Wenter, J.P. Müller, N.L. Albert, S. Lehner, W.P. Fendler, P. Bartenstein, et al.
The diagnostic value of [(18)F]FDG PET for the detection of chronic osteomyelitis and implant-associated infection.
Eur J Nucl Med Mol Imaging, 43 (2016), pp. 749-761
[28]
H. Hariri, S. Tan, P. Martineau, Y. Lamarche, M. Carrier, V. Finnerty, et al.
Utility of FDG-PET/CT for the detection and characterization of sternal wound infection following sternotomy.
Nucl Med Mol Imaging, 53 (2019), pp. 253-262
[29]
S. Liu, J. Zhang, H. Yin, L. Pang, B. Wu, H. Shi.
The value of 18 F-FDG PET/CT in diagnosing and localising deep sternal wound infection to guide surgical debridement.
Int Wound J, 17 (2020), pp. 1019-1027
[30]
A. Hartmann, K. Eid, C. Dora, O. Trentz, G.K. von Schulthess, K.D.M. Stumpe.
Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis.
Eur J Nucl Med Mol Imaging, 34 (2007), pp. 704-714
[31]
G.A. Govaert, F.F. IJpma, M. McNally, E. McNally, I.H. Reininga, A.W. Glaudemans.
Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis — a systematic review of the recent literature.
Eur J Nucl Med Mol Imaging, 44 (2017), pp. 1393-1407
[32]
H. Zhuang, J.W. Sam, T.K. Chacko, P.S. Duarte, M. Hickeson, Q. Feng, et al.
Rapid normalization of osseous FDG uptake following traumatic or surgical fractures.
Eur J Nucl Med Mol Imaging, 30 (2003), pp. 1096-1103
[33]
A. Elsheikh, M. Elazazy, M. Elkaramany.
Role of 18F-FDG PET-CT in pre-operative planning of surgical debridement in chronic osteomyelitis.
Indian J Orthop, 56 (2022), pp. 2237-2244
[34]
C. Love, M.B. Tomas, S.E. Marwin, P.V. Pugliese, C.J. Palestro.
Role of nuclear medicine in diagnosis of the infected joint replacement.
Radiographics, 21 (2001), pp. 1229-1238
[35]
B. Vanquickenborne, A. Maes, J. Nuyts, F. Van Acker, J. Stuyck, M. Mulier, et al.
The value of (18)FDG-PET for the detection of infected hip prosthesis.
Eur J Nucl Med Mol Imaging, 30 (2003), pp. 705-715
[36]
S.G. Pill, J. Parvizi, P.H. Tang, J.P. Garino, C. Nelson, H. Zhuang, et al.
Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip.
J Arthroplasty, 21 (2006), pp. 91-97
[37]
P. Reinartz, T. Mumme, B. Hermanns, U. Cremerius, D.C. Wirtz, W.M. Schaefer, et al.
Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning.
J Bone Joint Surg Br, 87-B (2005), pp. 465-470
[38]
F. Gemmel, H. Van den Wyngaert, C. Love, M.M. Welling, P. Gemmel, C.J. Palestro.
Prosthetic joint infections: radionuclide state-of-the-art imaging.
Eur J Nucl Med Mol Imaging, 39 (2012), pp. 892-909
[39]
F. Jamar, J. Buscombe, A. Chiti, P.E. Christian, D. Delbeke, K.J. Donohoe, et al.
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
J Nucl Med, 54 (2013), pp. 647-658
[40]
C.L. Romanò, N. Petrosillo, G. Argento, L.M. Sconfienza, G. Treglia, A. Alavi, et al.
The role of imaging techniques to define a peri-prosthetic hip and knee joint infection: multidisciplinary consensus statements.
J Clin Med, 9 (2020), pp. E2548
[41]
S.J. Verberne, R.J.A. Sonnega, O.P.P. Temmerman, P.G. Raijmakers.
What is the accuracy of nuclear imaging in the assessment of periprosthetic knee infection? A meta-analysis.
Clin Orthop Relat Res, 475 (2017), pp. 1395-1410
[42]
S.J. Gelderman, P.C. Jutte, R. Boellaard, J.J.W. Ploegmakers, D. Vállez García, G.A. Kampinga, et al.
18F-FDG-PET uptake in non-infected total hip prostheses.
Acta Orthop, 89 (2018), pp. 634-639
[43]
A. Rastogi, A. Bhattacharya, M. Prakash, S. Sharma, B.R. Mittal, N. Khandelwal, et al.
Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot’s neuroarthropathy.
Nucl Med Commun, 37 (2016), pp. 1253-1259
[44]
M. Vorster, J. Buscombe, Z. Saad, M. Sathekge.
Past and future of Ga-citrate for infection and inflammation imaging.
CPD, 24 (2018), pp. 787-794
[45]
M. Vorster, B. Mokaleng, M.M. Sathekge, T. Ebenhan.
A modified technique for efficient radiolabeling of 68Ga-citrate from a SnO2-based 68Ge/68Ga generator for better infection imaging.
Hell J Nucl Med, 16 (2013), pp. 193-198
[46]
T. Ebenhan, M.M. Sathekge, T. Lengana, M. Koole, O. Gheysens, T. Govender, et al.
68Ga-NOTA-functionalized ubiquicidin: cytotoxicity, biodistribution, radiation dosimetry, and first-in-human PET/CT imaging of infections.
J Nucl Med, 59 (2018), pp. 334-339
